User profiles for "author:Husam Abdel-Qadir"
Husam Abdel-QadirUniversity of Toronto Verified email at wchospital.ca Cited by 2904 |
Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: a systematic review and meta-analysis
Background The cardiovascular risk of angiogenesis inhibitors is not well-quantified. We
hypothesized that, compared to direct vascular endothelial growth factor (VEGF) inhibitors …
hypothesized that, compared to direct vascular endothelial growth factor (VEGF) inhibitors …
Statins and contrast-induced acute kidney injury with coronary angiography
Background Contrast-induced acute kidney injury is an adverse outcome resulting from
radiocontrast medium exposure during coronary angiography and percutaneous coronary …
radiocontrast medium exposure during coronary angiography and percutaneous coronary …
Machine learning compared with conventional statistical models for predicting myocardial infarction readmission and mortality: a systematic review
SM Cho, PC Austin, HJ Ross, H Abdel-Qadir… - Canadian Journal of …, 2021 - Elsevier
Background Machine learning (ML) methods are increasingly used in addition to
conventional statistical modelling (CSM) for predicting readmission and mortality in patients …
conventional statistical modelling (CSM) for predicting readmission and mortality in patients …
A population-based study of cardiovascular mortality following early-stage breast cancer
Importance There is increasing interest in the effect of cardiovascular disease on cancer
survivors. However, there are limited contemporary population-based data on the risk of …
survivors. However, there are limited contemporary population-based data on the risk of …
The association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcomes in anthracycline-treated patients with cancer
H Abdel-Qadir, R Carrasco, PC Austin, Y Chen, L Zhou… - Cardio Oncology, 2023 - jacc.org
Background Sodium glucose cotransporter-2 inhibitors (SGLT2is) are hypothesized to
reduce the risk of anthracycline-associated cardiotoxicity. Objectives This study sought to …
reduce the risk of anthracycline-associated cardiotoxicity. Objectives This study sought to …
Machine learning vs. conventional statistical models for predicting heart failure readmission and mortality
S Shin, PC Austin, HJ Ross, H Abdel‐Qadir… - ESC heart …, 2021 - Wiley Online Library
Aims This study aimed to review the performance of machine learning (ML) methods
compared with conventional statistical models (CSMs) for predicting readmission and …
compared with conventional statistical models (CSMs) for predicting readmission and …
Breast cancer therapy–related cardiac dysfunction in adult women treated in routine clinical practice: a population-based cohort study
P Thavendiranathan, H Abdel-Qadir… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Most women diagnosed with breast cancer are younger than 65 years of age.
Population-based studies on cancer therapy–related cardiotoxicity have focused on older …
Population-based studies on cancer therapy–related cardiotoxicity have focused on older …
Importance of considering competing risks in time-to-event analyses: application to stroke risk in a retrospective cohort study of elderly patients with atrial fibrillation
Background: Ignoring competing risks in time-to-event analyses can lead to biased risk
estimates, particularly for elderly patients with multimorbidity. We aimed to demonstrate the …
estimates, particularly for elderly patients with multimorbidity. We aimed to demonstrate the …
Statin Exposure and Risk of Heart Failure After Anthracycline‐or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort …
H Abdel‐Qadir, D Bobrowski, L Zhou… - Journal of the …, 2021 - Am Heart Assoc
Background Statins are hypothesized to reduce the risk of cardiotoxicity associated with
anthracyclines and trastuzumab. Our aim was to study the association of statin exposure …
anthracyclines and trastuzumab. Our aim was to study the association of statin exposure …
Cardiovascular risk associated with ibrutinib use in chronic lymphocytic leukemia: a population-based cohort study
PURPOSE Ibrutinib reduces mortality in chronic lymphocytic leukemia (CLL). It increases the
risk of atrial fibrillation (AF) and bleeding and there are concerns about heart failure (HF) …
risk of atrial fibrillation (AF) and bleeding and there are concerns about heart failure (HF) …